Fulgent Genetics (FLGT) Non Operating Income (2023 - 2026)
Fulgent Genetics' Non Operating Income history spans 4 years, with the latest figure at $8.6 million for Q1 2026.
- On a quarterly basis, Non Operating Income rose 12611.76% to $8.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$5.3 million, a 24.77% increase, with the full-year FY2025 number at $153000.0, down 72.73% from a year prior.
- Non Operating Income hit $8.6 million in Q1 2026 for Fulgent Genetics, up from -$14.0 million in the prior quarter.
- Over the last five years, Non Operating Income for FLGT hit a ceiling of $21.1 million in Q4 2023 and a floor of -$14.0 million in Q4 2025.
- Historically, Non Operating Income has averaged $1.4 million across 4 years, with a median of $46000.0 in 2025.
- Biggest five-year swings in Non Operating Income: tumbled 163.08% in 2024 and later skyrocketed 12611.76% in 2026.
- Tracing FLGT's Non Operating Income over 4 years: stood at $21.1 million in 2023, then crashed by 163.08% to -$13.3 million in 2024, then fell by 4.83% to -$14.0 million in 2025, then soared by 161.95% to $8.6 million in 2026.
- Business Quant data shows Non Operating Income for FLGT at $8.6 million in Q1 2026, -$14.0 million in Q4 2025, and -$5000.0 in Q3 2025.